» Articles » PMID: 30169655

A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2018 Update by the Infectious Diseases Society of America and the American Society for Microbiology

Abstract

The critical nature of the microbiology laboratory in infectious disease diagnosis calls for a close, positive working relationship between the physician/advanced practice provider and the microbiologists who provide enormous value to the healthcare team. This document, developed by experts in laboratory and adult and pediatric clinical medicine, provides information on which tests are valuable and in which contexts, and on tests that add little or no value for diagnostic decisions. This document presents a system-based approach rather than specimen-based approach, and includes bloodstream and cardiovascular system infections, central nervous system infections, ocular infections, soft tissue infections of the head and neck, upper and lower respiratory infections, infections of the gastrointestinal tract, intra-abdominal infections, bone and joint infections, urinary tract infections, genital infections, and other skin and soft tissue infections; or into etiologic agent groups, including arthropod-borne infections, viral syndromes, and blood and tissue parasite infections. Each section contains introductory concepts, a summary of key points, and detailed tables that list suspected agents; the most reliable tests to order; the samples (and volumes) to collect in order of preference; specimen transport devices, procedures, times, and temperatures; and detailed notes on specific issues regarding the test methods, such as when tests are likely to require a specialized laboratory or have prolonged turnaround times. In addition, the pediatric needs of specimen management are also emphasized. There is intentional redundancy among the tables and sections, as many agents and assay choices overlap. The document is intended to serve as a guidance for physicians in choosing tests that will aid them to quickly and accurately diagnose infectious diseases in their patients.

Citing Articles

An Evaluation of a Syndromic Molecular Panel in Optimising the Microbiological Diagnosis and Antimicrobial Therapy of Suspected Osteoarticular Infections in Paediatric Patients.

Agosta M, Cortazzo V, Onori M, Lucignano B, Vrenna G, Rossitto M Diagnostics (Basel). 2025; 15(5).

PMID: 40075813 PMC: 11899705. DOI: 10.3390/diagnostics15050566.


Detection of and (and Its Resistance to Ciprofloxacin): Validation of a Molecular Biology Tool for Rapid Diagnosis and Treatment.

Peris M, Alonso H, Escolar C, Tristancho-Baro A, Abad M, Rezusta A Antibiotics (Basel). 2024; 13(11).

PMID: 39596706 PMC: 11591347. DOI: 10.3390/antibiotics13111011.


A one-year hospital system review of plasma next-generation sequencing in a mixed population.

Drake T, Babic J, Wanger A, Chavez V Antimicrob Steward Healthc Epidemiol. 2024; 4(1):e211.

PMID: 39563930 PMC: 11574590. DOI: 10.1017/ash.2024.460.


Treatment with proton pump inhibitors is associated with secondary bacterial infections and sepsis in patients with COVID-19: a retrospective analysis of their joint impact on in-hospital prognosis.

Bianconi V, Mannarino M, Figorilli F, Ricciutelli F, De Carlo S, Zullo V Ann Med. 2024; 56(1):2399761.

PMID: 39475004 PMC: 11616760. DOI: 10.1080/07853890.2024.2399761.


The usage of immunosuppressant agents and secondary infections in patients with COVID-19 in the intensive care unit: a retrospective study.

Sarikaya Z, Gucyetmez B, Tuzuner F, Dincer O, Sahan C, Dogan L Sci Rep. 2024; 14(1):20991.

PMID: 39251824 PMC: 11385116. DOI: 10.1038/s41598-024-71912-3.